Dolutegravir + Rilpivirine
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Dolutegravir
dolutegravir - Rilpivirine
rilpivirine
Brands with this exact combination
| Brand | Composition & strength | Manufacturer |
|---|---|---|
| JulucaAU CA ES EU GB TW US |
| VIIV HEALTHCARE ULC |
| Dolutegravir 50mg / Rilpivirine 25mg tabletsAU ES GB | 50 mg / 25 mg | ViiV Healthcare Pty Ltd |
| dolutegravir sodium and rilpivirine hydrochlorideUS | 50 mg / 25 mg | ViiV Healthcare Company |
| dolutegravir + rilpivirinaES | 50 mg | Viiv Healthcare B.V. |
| dolutegravir + rilpivirine hydrochlorideAU | — | — |
| 滋若愷膜衣錠TW |
| 荷商葛蘭素史克藥廠股份有限公司台灣分公司 |
| JULUCA dolutegravir (as sodium) 50 mg/ rilpivirine (as hydrochloride) 25 mg tablet bottleAU |
| ViiV Healthcare Pty Ltd |
| JULUCA 50 mg/25 mg, comprimé pelliculéFR |
| VIIV HEALTHCARE (PAYS-BAS) |
| ジャルカ配合錠JP |
| ヴィーブヘルスケア |
Same combination in other markets
These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.
- CA · JULUCA · 1 products · record
- ES · JULUCA · 1 products · record
- GB · JULUCA · 1 products · record
- US · JULUCA · 1 products · record
- AU · JULUCA · 1 products · record
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.